These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9127623

  • 1. Therapeutic approaches to healing esophagitis.
    Boyce HW.
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [Abstract] [Full Text] [Related]

  • 2. Medical treatment of gastroesophageal reflux disease.
    Ljubicić N, Habijanić E, Antić Z, Doko M, Kovacević I, Zovak M.
    Acta Med Croatica; 1998 Apr; 52(2):133-8. PubMed ID: 9682502
    [Abstract] [Full Text] [Related]

  • 3. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Apr; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 4. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE.
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [Abstract] [Full Text] [Related]

  • 5. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996 Apr; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 6. [Recent topics in the medical treatment of reflux esophagitis].
    Hiraishi H, Shimada T, Terano A.
    Nihon Geka Gakkai Zasshi; 1997 Nov; 98(11):942-6. PubMed ID: 9488979
    [Abstract] [Full Text] [Related]

  • 7. Contemporary medical therapy for gastroesophageal reflux disease.
    Fass R, Hixson LJ, Ciccolo ML, Gordon P, Hunter G, Rappaport W.
    Am Fam Physician; 1997 Jan; 55(1):205-12, 217-8. PubMed ID: 9012279
    [Abstract] [Full Text] [Related]

  • 8. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ.
    J Assoc Acad Minor Phys; 2000 Jan; 11(1):7-11. PubMed ID: 10826019
    [Abstract] [Full Text] [Related]

  • 9. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G, Di Fede F.
    Clin Ther; 1993 Jan; 15 Suppl B():2-13. PubMed ID: 7911400
    [Abstract] [Full Text] [Related]

  • 10. [Internal medicine therapy in reflux disease].
    Flad J.
    Praxis (Bern 1994); 1996 Nov 05; 85(45):1432-8. PubMed ID: 8975352
    [Abstract] [Full Text] [Related]

  • 11. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC, Wolfe MM.
    Minerva Gastroenterol Dietol; 2004 Sep 05; 50(3):227-37. PubMed ID: 15729198
    [Abstract] [Full Text] [Related]

  • 12. [Comparison between histamine H2-blocker and proton pump inhibitor on the effects of initial treatment in reflux esophagitis].
    Harasawa S.
    Nihon Rinsho; 2000 Sep 05; 58(9):1847-52. PubMed ID: 11004814
    [Abstract] [Full Text] [Related]

  • 13. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ.
    Gastroenterol Clin North Am; 1990 Sep 05; 19(3):683-712. PubMed ID: 1977703
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ, Hunt RH.
    Best Pract Res Clin Gastroenterol; 2001 Jun 05; 15(3):355-70. PubMed ID: 11403532
    [Abstract] [Full Text] [Related]

  • 15. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Scarpignato C.
    Dig Liver Dis; 2005 Jul 05; 37(7):468-74. PubMed ID: 15893968
    [No Abstract] [Full Text] [Related]

  • 16. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA, Kuppermann M, Richter JE.
    Am J Gastroenterol; 1997 Dec 05; 92(12):2179-87. PubMed ID: 9399748
    [Abstract] [Full Text] [Related]

  • 17. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
    Chiba N.
    Can J Gastroenterol; 1997 Sep 05; 11 Suppl B():66B-73B. PubMed ID: 9347181
    [Abstract] [Full Text] [Related]

  • 18. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Tuynman HA, Voskuil JH, Devillé WL, Meuwissen SG.
    Am J Gastroenterol; 1997 Sep 05; 92(9):1475-9. PubMed ID: 9317066
    [Abstract] [Full Text] [Related]

  • 19. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr 05; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 20. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN.
    Scand J Gastroenterol Suppl; 1989 Apr 05; 168():38-49. PubMed ID: 2575792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.